By backing the wholesale repeal of the 2010 health care law, President Donald Trump could unravel his own plan on prescription drug prices and undermine his messaging on an important issue ahead of the 2020 election: the climbing cost of medicines.
Less than two weeks before the midterm elections last year, Trump delivered a proposal to rein in the costs of outpatient drugs by pegging them to the lower prices paid by foreign countries.
The policy was endorsed by advocates for lower drug prices and denounced by the powerful lobby for drugmakers, appearing to fulfill a promise Trump made in a speech in the Rose Garden earlier that year to take on the Big Pharma “gravy train.”
View the complete March 29 article by Emily Kopp on The Roll Call website here.